Abstract:1. We examined the effects of frequencies and patterns of electrical stimulation of the peripheral cut ends of the vagus nerves on the release of mucus glycoconjugates into feline trachea in vivo. Mucus glycoconjugates, radiolabelled biosynthetically with [35S]sulphate and [3H]glucose, were washed from a tracheal segment in situ, and dialysed before being counted and assayed chemically by the periodic acid-Schiff (PAS) method. 2. Vagal stimulation with regular pulses (10 V, 2 ms duration) at 1, 2.25, 4.5, 9 and 18 Hz produced frequency-dependent increases in the output of mucus glycoconjugates. 3. The muscarinic agonist pilocarpine (0.1-10 microM), given intrasegmentally, produced dose-dependent increases in the output of mucus glycoconjugates. 4. Pretreatment with atropine, phentolamine and propranolol reduced but did not abolish the effects of vagal stimulation. Vagus nerve stimulation still caused frequency-dependent increases in the output of mucus glycoconjugates. 5. High frequency stimulations at 22.5 and 47.5 Hz given intermittently (1 s burst then 4 s rest), whether in the absence or presence of cholinergic and adrenergic blockade, produced similar secretory responses as the same number of pulses delivered in regular trains at 4.5 and 9.5 Hz. This suggests that neither cholinergic nor non-adrenergic, non-cholinergic (NANC) nerve mechanisms in this system are potentiated by high frequency, intermittent burst stimulation. 6. In the absence of atropine, regular vagal stimulation had a greater effect on heart rate than did the same number of pulses delivered in bursts. 7. High molecular weight glycoconjugates from secretions were taken from the void volume of a Sepharose CL-2B gel filtration column and separated further by density-gradient centrifugation. Macromolecular components were observed at two densities, a typical mucin at 1.52 g ml-1, and a high density atypical component at 1.63 g ml-1. In secretions collected during vagal stimulation, either in the absence or presence of cholinergic and adrenergic blockade, the ratio of low density to high density macromolecules was higher than in unstimulated secretions. This can be explained if both cholinergic and NANC nervous vagal mechanisms stimulate the output of typical (density = 1.52 g ml-1) mucins into the feline trachea.

Effect of various modes of tracheal mechanical stimulation on the cough motor pattern

Airway mechanics alters generation of cough motor pattern

Changes in vagal afferent drive alter tracheobronchial coughing in anesthetized cats

Modeling and simulation of vagal afferent input of the cough reflex

Role of the pontine respiratory group in the suppression of cough by codeine in cats

Computational Modelling of Cough Function and Airway Penetrant Behavior in Patients with Disorders of Laryngeal Function

Brainstem processing of cough sensory inputs in chronic cough hypersensitivity

Effects of transcranial direct current stimulation on cough reflex and urge-to-cough in healthy young adults

Central nervous mechanisms of cough.

Depression of cough reflex by microinjections of antitussive agents into caudal ventral respiratory group of the rabbit

A Preliminary Study of Voluntary Cough Motor Performance and Learning With Skill Training and Biofeedback

Profile of cough triggers and their relationship with capsaicin cough sensitivity in chronic cough

Transcutaneous auricular vagus nerve stimulation alters cough sensitivity depending on stimulation parameters: potential implications for aspiration risk

Dual Tasking Influences Cough Sensorimotor Outcomes in Healthy Young Adults

Effect of transient receptor potential vanilloid-1 on cough hypersensitivity induced by particulate matter 2.5

Sensorimotor circuitry involved in the higher brain control of coughing

Bronchodilator therapy for chronic cough

Vagal control of mucus glycoconjugate secretion into the feline trachea

Enhancing Cough Motor Learning in Parkinson's Disease Through Variable Practice During Skill Training

Influence of combined voltage-gated sodium channel NaV1.7 and NaV1.8 inhibitors on cough in a guinea pig model

Laryngeal Vibrotactile Stimulation Is Feasible, Acceptable To People With Unexplained Chronic Cough